Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|HER2 Positive|Combination Chemotherapy
Interventions: DRUG: Pyrotinib Maleate Tablets|DRUG: Albumin Paclitaxel|DRUG: Trastuzumab
Sponsor: West China Hospital
Collaborators: Jiangsu HengRui Medicine Co., Ltd.